Opioid-free Anesthesia and Acute Postoperative Pain

Sponsor
Attikon Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04976842
Collaborator
(none)
200
1
2
36
5.6

Study Details

Study Description

Brief Summary

Control of intraoperative and postoperative pain with the use of opioids constitutes normal practice. Opioid free anesthesia (OFA) is a relatively recent anesthesiology practice according to which opioids are not administered during surgery and are avoided postoperatively. Opioid free anesthesia seems to provide better quality of postoperative analgesia while protecting the patient from the side effects of opioids such as respiratory depression, postoperative nausea and vomiting (PONV), opioid induced hyperalgesia and postoperative cognitive dysfunction. The aim of this study is to investigate the possible difference in the intensity of postoperative pain (based on the numeric rating scale 0-10) and the presence of PONV in patients undergoing transurethral urologic surgery under general anesthesia, when patients receive randomly either opioid free anesthesia (OFA) or opioid based anesthesia (OBA).

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

This study aimed to study postoperative pain after opioid free anesthesia or opioid based anesthesia after urologica; procedures. The two study groups opioid free (OFA) and opioid based (OBA) were as follows:

OFA: Anesthesiology technique based on Mulier protocol. Before induction, loading dose of dexmedetomidine 0,25mcg/kg (max 20mcg). Induction with dexmedetomidine 0,1mcg/kg, lidocaine 1mg/kg, ketamine 0,1mg/kg plus propofol 2mg/kg plus rocuronium1mg/kg IBW (if required). Maintenance with dexmedetomidine 0,1mcg/kg/h, lidocaine 1mg/kg/h, ketamine 0,1mg/kg/h and propofol infusion adjusted according to bispectral index indication ( BIS maintained 40-60). 15 minutes prior to end of surgery, the dose of drugs is reduced to dexmedetomidine 0,05mcg/kg/h, lidocaine 0,5mg/kg/h, ketamine 0,05mg/kg/h.

OBA: Total intravenous anesthesia with propofol for maintenance of anesthesia. Fentanyl 2mcg/kg only at induction and infusion of propofol and remifentanil for maintenance, with doses adjusted according to bispectral index indication ( BIS maintained 40-60).

Both groups receive ranitidine 50mg, dexamethasone 4 mg and paracetamol 1g iv 15 min before the end of surgery. Postoperative analgesia for both groups consists of paracetamol 3g/24h iv, rescue analgesia with tramadol 1mg/kg iv max x3, rescue for PONV ondacetron 4 mg iv.

The outcomes assessed were:
Primary outcome:
  1. Intensity of acute postoperative pain (NRS 0-10), time frame up to 24h postoperatively

  2. Nausea and vomiting

Secondary outcome:
  1. Change in minimental state evaluation test, time frame pre-op, 1h post-op, at discharge

  2. Severe postoperative adverse effect related to anesthesia (postoperative hypoxemia, ileus, postoperative cognitive dysfunction)

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
2 groups of patients assigned to either opioid-free anesthesia or opioid-based anesthesia were studied in a randomized manner as for postoperative pain and cognitive dysfunction2 groups of patients assigned to either opioid-free anesthesia or opioid-based anesthesia were studied in a randomized manner as for postoperative pain and cognitive dysfunction
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
the investigator assessing outcome did not know the kind of anesthesia the patient received
Primary Purpose:
Treatment
Official Title:
Acute Postoperative Pain in Opioid-free Anesthesia After Urological Procedures
Actual Study Start Date :
Aug 1, 2019
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Opioid-free anesthesia

Opioid free anesthesia protocol for urological procedurs

Device: OFA
Anesthesiology technique based on Mulier protocol. Before induction, loading dose of dexmedetomidine 0,25mcg/kg (max 20mcg). Induction with dexmedetomidine 0,1mcg/kg, lidocaine 1mg/kg, ketamine 0,1mg/kg plus propofol 2mg/kg plus rocuronium1mg/kg IBW (if required). Maintenance with dexmedetomidine 0,1mcg/kg/h, lidocaine 1mg/kg/h, ketamine 0,1mg/kg/h and propofol infusion adjusted according to bispectral index indication ( BIS maintained 40-60). 15 minutes prior to end of surgery, the dose of drugs is reduced to dexmedetomidine 0,05mcg/kg/h, lidocaine 0,5mg/kg/h, ketamine 0,05mg/kg/h.

Active Comparator: Opioid-based anesthesia

Opioid based anesthesia protocol for urological procedures

Drug: OBA
Total intravenous anesthesia with propofol for maintenance of anesthesia. Fentanyl 2mcg/kg only at induction and infusion of propofol and remifentanil for maintenance, with doses adjusted according to bispectral index indication ( BIS maintained 40-60).

Outcome Measures

Primary Outcome Measures

  1. postoperative pain [baseline and 24 hours]

    Intensity of acute postoperative pain (measured by numeric rating scale NRS 0-10), time frame up to 24h postoperatively

Secondary Outcome Measures

  1. postoperative cognitive dysfunction [baseline and 24 hours]

    Change in minimental state evaluation test up to 24 hours postoperatively

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients aged>18 years old

  • ASA I-III

  • Patients scheduled for elective transurethral urologic surgery with general anesthesia

Exclusion Criteria:
  • • Patient refusal

  • Use of opioids pre-op

  • Inability to read or write

  • Known psychiatric disease under medication

  • Dementia

  • Severe liver and renal disease

  • Known allergy to drugs used

  • Known arrhythmia (2nd-3rd AV block, acute unstable angina, acute myocardial infarction in the past 6 weeks or severe cardiac problem-condition)

  • Heart rate<45 bpm

  • Pre-op minimental test<23

  • Major surgery complications (hemorrhage with need for transfusion)

Contacts and Locations

Locations

Site City State Country Postal Code
1 2nd Department of Anesthesiology, Attikon Hospital, 1 Rimini str. Athens Greece 12462

Sponsors and Collaborators

  • Attikon Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Chrysanthi Batistaki, Associate Professor of Anaesthesiology, Attikon Hospital
ClinicalTrials.gov Identifier:
NCT04976842
Other Study ID Numbers:
  • OFA 1
First Posted:
Jul 26, 2021
Last Update Posted:
Aug 13, 2021
Last Verified:
Aug 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Chrysanthi Batistaki, Associate Professor of Anaesthesiology, Attikon Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 13, 2021